Literature DB >> 2306708

Carcinogenicity studies with deltamethrin in mice and rats.

J R Cabral1, D Galendo, M Laval, N Lyandrat.   

Abstract

The pesticide Deltamethrin, a synthetic pyrethroid, was studied for carcinogenicity in long-term experiments in mice and rats. Mice were given Deltamethrin by gavage in arachis oil at 0, 1, 4 or 8 mg/kg body wt for 2 years. A group of untreated controls was also available. Rats received 0, 3 or 6 mg/kg body wt. Deltamethrin in arachis oil for 2 years. In mice, an increased incidence of lymphomas was observed in the groups receiving 1 and 4 mg/kg body wt., but not in the group treated with 8 mg/kg body wt. Deltamethrin. In rats, an increased incidence of thyroid tumours was noted, but, no clear dose-response relationship was shown. Deltamethrin does not appear to be carcinogenic in mice or rats, but further studies are needed on the group of compounds to which this substance belongs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306708     DOI: 10.1016/0304-3835(90)90151-m

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Immunoassays and biosensors for monitoring environmental and human exposure to pyrethroid insecticides.

Authors:  Ki Chang Ahn; Hee-Joo Kim; Mark R McCoy; Shirley J Gee; Bruce D Hammock
Journal:  J Agric Food Chem       Date:  2010-11-24       Impact factor: 5.279

Review 2.  Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993.

Authors:  L S Gold; N B Manley; T H Slone; G B Garfinkel; B N Ames; L Rohrbach; B R Stern; K Chow
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

Review 3.  A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests.

Authors:  Qianying Liu; Zhixin Lei; Feng Zhu; Awais Ihsan; Xu Wang; Zonghui Yuan
Journal:  Front Public Health       Date:  2017-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.